CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 277884-277974 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"A follow-up liver biopsy after 6 months of the infliximab showed no granulomatous lesions.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T58687","span":{"begin":0,"end":90},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T58687","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T20","span":{"begin":0,"end":90},"obj":"Sentence"}],"attributes":[{"subj":"T20","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T612","span":{"begin":12,"end":17},"obj":"Body_part"}],"attributes":[{"id":"A612","pred":"uberon_id","subj":"T612","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"subj":"T612","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecdf93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#c593ec"},{"id":"CORD-19-PD-UBERON","color":"#93ecab"}]}]}}